Search for an ETF or holding
WAVERLEY PHARMA INC (WAVE.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 540,000 CAD (micro-cap).
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.